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Abstract   
It is well established that glucocorticoids elevate the production of fibroblast-pneumocyte 
factor (FPF), which induces type II cells to synthesize surfactant phospholipids. FPF, 
however, has not been identified and it is not clear whether it is a single factor or a complex 
mixture of factors. In this study it has been shown that, when lung fibroblasts are exposed to 
dexamethasone, the concentration of neuregulin-1β (NRG1β) in conditioned medium is 
elevated 2-fold (p < 0.05), even though NRG1β gene expression is unaffected. This, together 
with the finding that exposure of type II cells to NRG1β directly stimulates by 3-fold the rate 
of phospholipid synthesis (p < 0.05), suggests that NRG1β is a component of FPF that 
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The fetal lung undergoes extensive physiological and biochemical maturation prior to birth in 
preparation for its postnatal function as an organ for gas exchange. Pulmonary surfactant, a 
substance that reduces surface tension and prevents alveolar collapse, is produced by type II 
pneumocytes in the developing lung [1,2]. Any reduction in the ability of type II cells to 
produce surfactant leads to neonatal respiratory distress syndrome (NRDS) [1]. Synthesis of 
the major phospholipid component of surfactant, phosphatidylcholine, was shown to be 
stimulated by glucocorticoids [3] even though they have no effect when directly applied to 
type II cells. However, when lung fibroblasts were cultured in the presence of glucocorticoids, 
the resultant fibroblast-conditioned media (FCM) is known to stimulate surfactant production 
in cultured type II cells [4]. This indirect effect of glucocorticoids upon surfactant 
phospholipid synthesis was attributed to a fibroblast-derived peptide, termed fibroblast-
pneumocyte factor (FPF) [5]. It was subsequently reported that purified FPF was able to 
directly stimulate the synthesis of surfactant-associated phospholipids [6]. Even though 
several peptides have been shown to have properties similar to FPF [7-9], the chemical nature 
of FPF is still not certain. 
Torday et al. [7] have shown that leptin, a 16 kDa peptide expressed by fetal lung fibroblasts, 
stimulates de novo synthesis of surfactant phospholipids in type II cells. Coupled with the 
observation that dexamethasone, which is known to stimulate production of FPF, also 
stimulated expression of leptin mRNA, they concluded that leptin might be FPF [7]. 
However, neuregulin-1β (NRG1β) has also been shown to play a major role in the 
development and maturation of the fetal lung. Dammann et al. [8] provided evidence that the 
stimulation of surfactant synthesis in type II cells by media previously conditioned by 
fibroblasts in the presence of dexamethasone can be mimicked by NRG1β and inhibited by 




Neuregulins are part of the epidermal growth factor (EGF) family [10], and interact with 
several members of the ErbB family of receptors [11]. NRG1β is known to have a role in the 
early stages of lung development [12], and ErbB receptors are distributed throughout the 
developing lung [12,13]. Dammann et al. showed that dexamethasone, a steroid used to 
stimulate production of FPF by fibroblasts, also regulated levels of ErbB receptors in the fetal 
lung [14]. Zscheppang et al. used small interfering RNA to show that ErbB4 regulates 
surfactant phospholipid synthesis in the fetal rat type II cells [15].  
Surfactant production is also induced by keratinocyte growth factor (KGF) [16-18], otherwise 
known as fibroblast growth factor 7. This peptide is a product of lung mesenchymal cells and 
stimulates both the synthesis of the major component of surfactant, disaturated 
phosphatidylcholine, as well as the expression of the SP-A, -B and –C genes in a dose-
dependent manner [17]. However, although KGF has many of the properties of FPF, its size 
(28 kDa) [19] is much larger than the 5-15 kDa ascribed to FPF [20]. Thus, in this study the 
focus was on the specific effects of leptin and neuregulin-1β on surfactant phospholipid 
synthesis and secretion in cultured fetal type II pneumocytes.  
From the above it is clear that NRG1β performs an important role in this system, although the 
exact details of the mechanism have not been elucidated. In this study we have examined the 
effect of NRG1β on surfactant phospholipid synthesis over a range of concentrations and 
exposure times, and have also compared the effects of NRG1β and leptin on this synthesis. In 
addition, the effect of dexamethasone on NRG1β production by fibroblast cells, including 
mRNA expression and direct quantification using liquid chromatography-mass spectrometry 







Materials and Methods 
Animals 
Nineteen-day pregnant rats of the Wistar strain of Rattus norvegicus (22-day gestation period) 
were supplied by the Animal Resource Centre (Murdoch, Australia). The presence of sperm 
in a vaginal smear after overnight mating indicated conception had occurred and was 
designated day zero. Experiments complied with National Health and Medical Research 
Council guidelines, and were approved by the university’s Animal Ethics Committee.   
Materials 
Eagle’s minimal essential medium (MEM) and newborn bovine serum (NBCS) were obtained 
from Thermo Fisher Scientific (Waltham, USA). Radiolabelled compounds were supplied by 
GE Healthcare (Little Chalfont, UK). HPLC grade acetonitrile was obtained from Burdick 
and Jackson (Muskegon, USA) and water was obtained from a Milli-Q system (Millipore 
Corp., Billerica, USA). Lyophilized recombinant human neuregulin-1β (heregulin-1β, 
7.5 kDa) (PeproTech, Rocky Hill, USA) was reconstituted in Milli-Q water. The SV total 
RNA isolation and OneStep RT-PCR kits used for RT-PCR reactions were purchased from 
Promega Corporation (Madison, WI, USA) and Qiagen Sciences (Germantown, MD, USA), 
respectively. All other reagents were supplied by Sigma Aldrich (St. Louis, USA).  
Preparation of media  
Eagle’s minimal essential medium was reconstituted according to the manufacturer’s 
specifications, supplemented with 0.2% NaHCO3 and adjusted to pH 7.4. To this was added 
L-glutamine, penicillin G and streptomycin sulfate to final concentrations of 2.6 mM, 
100 IU/mL and 135 μM, respectively. The medium was then sterilized by filtration through a 
0.22 μm filter and amphotericin was added to a final concentration of 3.2-3.6 μg/mL. The 




Isolation of fibroblasts and type II pneumocytes 
Pregnant rats (19 days gestation) were asphyxiated with CO2 and fetuses delivered by 
Caesarean section. The fetal lungs were removed, minced and incubated with collagenase 
(0.05 IU.mL
-1
) for 20 minutes in a 37°C shaking water bath, as previously described [21,22]. 
After filtration through two layers of sterile French voile, the cells were centrifuged at 20 g 
for 2 min and the pellet resuspended in serum-free medium. This suspension was plated 
(6 lungs per plate) onto 6 cm diameter culture plates (Corning Life Sciences, Lowell, USA) 
and incubated for 30 minutes at 37°C in a humidified CO2 incubator to allow adhesion of 
fibroblasts. Non-adhering cells were removed by gentle swirling and the medium replaced 
with serum-containing media. The non-adhering cells were used to isolate type II 
pneumocytes, according to the method of Dobbs et al.[23]. The type II cell medium was 
changed after 24 and 72 h. When the cells had been cultured for 3 days the cultures were 
nearly confluent and consisted predominantly of differentiated type II cells, each containing 
numerous lamellar bodies and being capable of both synthesis [21] and secretion [22,24] of 
surfactant phosphatidylcholine. 
Preparation of fibroblast-conditioned medium 
Confluent fibroblast cultures were considered free of contamination from type II cells as 
judged by microscopy. Media was removed from the plates and replaced with serum-free 
medium supplemented with either dexamethasone in propylene glycol or vehicle (control). 
Plates were returned to the incubator for a further 24 hours, after which FCM was collected 
and stored at -80°C. Prior to assay, each FCM was thawed and heat-treated at 65°C for 60 
minutes to remove known inhibitory factors [5]. After cooling to room temperature, they were 






Assay of synthesis of surfactant phospholipids 
The medium from confluent type II pneumocyte cultures was removed and replaced with 
3.0 mL of either diluted FCM supplemented with the corresponding additives or serum-free 
media supplemented with the indicated concentrations of heregulin-1β or leptin. After 21 h of 
culture, serum-free medium containing [methyl-
3
H]-choline chloride (final concentration 
1.0 μCi/mL) was added and the plates further incubated for the indicated times. After this 
final incubation, incorporation of [
3
H]-choline into cellular surfactant phospholipid (expressed 
as dpm/µg DNA) was determined as described by Sen and Cake [21]. The radiolabelled 
material produced using this method was previously validated using TLC and shown to 
consist predominantly (> 85%) of phosphatidylcholine (PC), of which disaturated PC was the 
major component [22]. 
RT-PCR quantification   
The RT-PCR primers for the GAPDH and NRG1β mRNA assays were designed to include a 
splice junction between the forward and reverse primers thereby providing the means of 
distinguishing between the products of mRNA and genomic DNA based on the size of the 
products. Each of the primers were checked for melting temperature (TM) and cross reactivity 
with other sequences using Primer3 and BLAST software, respectively. Agarose 
electrophoresis of the RT-PCR products demonstrated that neither primer dimer formation nor 
interference with GAPDH primers were evident. The forward and reverse primer sequences 
chosen for the GAPDH and NRG1β RT-PCR assays are shown below:   
Primer Size (bp) Forward primer sequence Reverse primer sequence 
GAPDH 207 5’-agacagccgcatcttcttgt-3’ 5’-cttgccgtgggtagagtcat-3’ 
NRG1β 196 5’-acgactgggaccagccatc-3’ 5’-tctggtagagttcctccgctttg-3’ 
 
GAPDH and NRG1β TaqMan probes, which had melting temperatures approximately 10ºC 




quencher at the 3’ end and FAM (green) or Cy5 (red) covalently attached at the 5’ end, 
respectively. The sequence of these probes is shown below:  
Probe Dye TaqMan probe sequnce 
GAPDH FAM 5’(FAM)-ccgtgtgaacggatttggccgtatc-(IABkFQ) 3’ 
NRG1β Cy5 5’(Cy5)-tggcaacgatcaccagtaaactcatttgg-(IAbRQSp) 3’ 
 
Total cellular RNA was extracted using a SV Total RNA Isolation System (Promega 
Corporation, Madison, WI, USA). All pipette tips and microcentrifuge tubes used were 
certified nuclease-free. Following extraction, RNA extracts were stored at -70°C until 
quantification. RNA quantification of each extract was made using an Agilent 2100 
Bioanalyzer with an Agilent RNA 6000 Pico kit (Agilent Technologies Inc., Santa Clara, CA, 
USA). The extracts were diluted such that an aliquot containing 5 ng of mRNA was added to 
each RT-PCR.  
To measure relative gene expression, QIAGEN OneStep RT-PCR was undertaken using a 
QIAGEN Rotor-Gene Q6000 (QIAGEN, Hilden, Germany). For each RNA extract, a PCR 
reaction was set-up in a UV-sterilised, RNase-free PCR tube (Axygen - Fisher Biotec, Perth, 
Western Australia), containing forward and reverse primers as well as the TaqMan probes for 
GAPDH and NRG1β. It was established that an annealing temperature of 57ºC provided the 
best specificity and the highest yield of product. Thus, the reaction mixtures were incubated at 
50°C for 30 minutes followed by denaturation at 95ºC for 15 minutes. This was followed by 
40 cycles using the following parameters; 94°C for 30 sec; 57°C for 30 sec and 72°C for 
60 sec. The reactions were then held at 72°C for 10 minutes. The RT-PCR products were then 
analysed for the expression of NRG1β relative to GAPDH using the method of Pfaffl [25]. 
Liquid chromatography-mass spectrometry (LC-MS) 
Mass spectrometry was undertaken using an Agilent Classic series ion trap mass 




Nebulizer pressure was set at 35 psi and drying gas was set at 10 L/min of N2 and 325°C. 
Standards and samples were infused directly into the MS at 5 μL/min
 
using a KD Scientific 
100 syringe pump (KD Scientific, Holliston, USA). Two identifier ions were selected: 
m/z 1068.5 ([M+7H]
7+
), and 1246.7 ([M+6H]
6+
). MS/MS was performed on m/z 1068.5, and 




) and 1047.3 were 
selected. 
To allow quantification, an Agilent 1100 capillary HPLC (Agilent Technologies) was coupled 
to the ion trap MS. The analytical column used was an Agilent Zorbax 300SB-C18 capillary 
column with dimensions of 100 mm x 0.3 mm with 3.5 μm particle size. Mobile phase 
solvents consisted of (A) water + 0.1% formic acid and (B) acetonitrile + 0.1% formic acid. 
Flow rate was set at 5 μL/min with a gradient as follows (A:B): 0 min – 90:10, 
10 min - 90:10, 25 min – 0:100, 35 min – 0:100. Standard NRG1β eluted at a retention time of 
12.5 minutes, and a standard curve for NRG1β was prepared in triplicate over the range of 
0.01 to 1.33 nM. This curve showed a very strong correlation (R = 0.998). 
Data analysis  
Statistical analyses were performed using SPSS Statistics for Windows 21.0.  Repeated 
measures ANOVA [26] was used to analyze the time-course experiment and for ascertaining 
differences between 3 or more experimental conditions. If significance was determined in the 
later case, the ANOVA was followed by Dunnett pairwise comparisons of the various groups. 
LC-MS analysis was undertaken using Agilent ChemStation for LC 3D (Rev. B.09.03) and 
Bruker-Daltonik MSD Trap Control software (v. 5.1) (Bruker-Daltonik, Bremen, Germany). 
Results and Discussion   
Effect of fibroblast-conditioned medium on surfactant phospholipid synthesis 
Six pairs of control and dexamethasone-treated FCM were assayed for their effect on 




presence of 100 nM dexamethasone enhanced by 24% the rate of surfactant phospholipid 
synthesis by type II cells when compared to that measured in control cultures (Figure 1A; 
p < 0.05). Previously, this increase has been ascribed to the generation of FPF, which is 
produced by lung fibroblasts and acts on type II pneumocytes to enhance surfactant 
phospholipid synthesis [6,27]. Dammann et al. [8] observed  that 1 and 10 nM NRG1β were 
able to mimic  the  effect of  FPF, suggesting that it may be involved in the FPF response.  
In order to quantify the amount of NRG1 present, the same six pairs of control and 
dexamethasone-treated FCM that were used above were also analysed by LC-MS. The mean 
NRG1β concentration in the control FCM was 2.65  0.23 nM, while in the test FCM it was 
5.55  0.19 nM (Figure 1B). These findings indicate that fibroblast cells produce and secrete 
NRG1β in the absence of dexamethasone stimulation, but that its concentration was more 
than two-fold higher when the fibroblasts were exposed to dexamethasone (p < 0.001). This 
observation may account for the finding of Dammann et al. [8] that NRG1β antibody is able 
to block the enhanced rate of surfactant synthesis in type II cells that had been exposed to 
FCM. 
It is important to note that the effects of dexamethasone on expression and activation of ErbB 
receptors in fetal mouse type II cells were distinct from those induced by mature (d18) FCM 
[14]. Thus, in order to ascertain whether the glucocorticoid-induced increase in NRG1β 
mimics natural maturation processes, additional experiments should be conducted to 
determine the NRG1β concentration in media conditioned by lung fibroblasts isolated from 
fetal rats of different gestation ages.  
Effect of NRG1β on surfactant phospholipid synthesis 
When type II cells were incubated with NRG1β in the range 0 - 26.67 nM for 21 hours, the 
quantity of labelled surfactant phospholipid synthesised after 6 hours was higher in those cells 




3648 ± 239 dpm/μg DNA, compared to 1045 ± 137 dpm/μg DNA in control cells. Similar 
NRG1β dose-response curves have been seen with other cell types [28,29]. The increased 
level of surfactant phospholipid synthesis in cells exposed to either 2.67 or 6.67 nM NRG1β 
(3269.6 ± 616.4 dpm/μg DNA) was significantly different from that in the controls (more than 
3-fold higher; p < 0.05) (Figure 2A). It is important to note that the control cells in this 
experiment were incubated with MEM
+
 whereas those in the experiment reported in Figure 
1A were incubated with FCM, which contains approximately 0.66 nM NRG1β (after being 
diluted 1:4) together with any other components of FPF (Figure 1B). It is thus not surprising 
that the level of phospholipid synthesis is much lower in those cells maintained in MEM
+ 
and 
that the observed response to NRG1β is greater.         
The response to NRG1 was reduced at higher concentrations of the ligand, and it is likely 
that the ErbB receptor to which NRG1β binds was down-regulated at these concentrations. 
Although the mechanism by which this down-regulation might occur in type II cells is 
unknown, Cao et al. [30] have shown that neuregulin induces both ubiquitination and 
degradation of the ErbB3 receptor in MCF-7 cells. If neuregulin-induced degradation of the 
ErbB receptor also occurs in type II cells this could explain the decline in the response at 
higher concentrations of NRG1β. In the current study, the commercially available form of 
NRG1β (heregulin-1β) was used whereas the form used in the study by Dammann et al. [8] is 
not known. Despite this, as well as the fact that the type II cells were derived from rats and 
mice, respectively, elevated phospholipid synthesis by these cells was evident at similar 
NRG1β concentrations.         
The quantity of radiolabelled surfactant phospholipids synthesised by type II pneumocytes in 
the 2, 4 and 6 hours following 21 hours incubation with 6.67 nM NRG1β was enhanced when 
compared with that which occurred in cells grown in the absence of NRG1β (Figure 2B). The 




dpm/μg DNA at 6 hours, while NRG1β-treated cells increased from 1219.4 ± 208.8 dpm/μg 
DNA at 2 hours to 2469.6 ± 184.1 dpm/μg DNA at 6 hours. The difference between control 
cultures and NRG1β-treated cells was significant (p < 0.05) and, as expected, there was also 
evidence of an increase in the rate of phospholipid synthesis with time (p < 0.01).  
In order to understand the mechanism(s) by which NRG1β exerts its effect it needs to be 
recognized that, in mice and rats, the response of lung cells to this peptide is mediated via 
ErbB receptors [14,15,31]. Using a small interfering RNA (siRNA), which targeted the ErbB4 
gene and silenced ErbB4 receptor activity in cultured 19-day fetal type II pneumocytes, 
Zscheppang et al. [15] demonstrated that the resulting down-regulation of the ErbB4 receptor 
caused a diminished rate of surfactant phospholipid synthesis. Their conclusion that the 
response of these cells to NRG1β is mediated through ErbB4 receptor activation was 
supported by the observation that exposure of both fetal and adult rat lung epithelial cells to 
NRG1β resulted in increased phosphorylation of the ErbB4 receptor [13,32]. 
NRG1β mRNA expression 
RT-PCR analysis of the level of expression of the NRG1β gene in cultured fetal lung 
fibroblasts following exposure to dexamethasone showed no significant difference with either 
20 or 50 nM dexamethasone (Table 1). The fold change in NRG1β mRNA levels, relative to 
that of GAPDH, after exposure to 20 nM dexamethasone ranged from 0.93-fold at 4 hours to 
0.73-fold at 24 hours, while with 50 nM dexamethasone, changes ranged from 0.95-fold at 
4 hours to 1.10-fold at 24 hours. Preliminary experiments conducted after 2 and 6 h exposure 
to the steroid also showed no significant elevation of NRG1β gene expression. The absence of 
a significant increase in NRG1β gene expression following exposure to dexamethasone 
suggests that the steroid does not mediate its effects via an elevated rate of transcription of the 
NRG1β gene. It is well known that at least 15 different isoforms of NRG1β are produced 




[33]. Given that neuregulins are produced as transmembrane precursors, which are considered 
to generate diffusible ligands when subjected to cleavage [34,35], it is possible that 
dexamethasone stimulates the rate of cleavage of the neuregulin precursors. In this context it 
is relevant that glucocorticoids enhance proteolytic activity in both muscle cells and 
thymocytes [36,37]. Alternatively, dexamethasone may induce secretion of pre-formed 
NRG1β followed by new NRG1β synthesis more than 24 h later. Thus, any transient increase 
in NRG1β gene expression may occur 24 h or more after exposure to dexamethasone.             
Comparison of NRG1β and leptin effects on surfactant phospholipid synthesis 
Previous studies have shown that leptin, which is expressed by lipofibroblasts during rat lung 
development, has many of the characteristics of FPF [7,38]. Leptin, at both 
1.24 (5245.8 ± 906.1 dpm/μg DNA) and 3.09 nM (5691.0 ± 533.4 dpm/μg DNA), showed a 
significant increase in surfactant phospholipid synthesis compared to the control 
(3183.8 ± 349.9 dpm/μg DNA) (p < 0.05 and p < 0.01, respectively), but not at 6.17 nM 
(4405.4 ± 174.4 dpm/μg DNA). Similar results were obtained by Torday et al. [7] although, in 
their study, there was no decline in the response to the higher leptin concentration. When one 
compares the response of these cells to leptin (Figure 3) with that of NRG1β (Figure 2A) it is 
apparent that both peptides stimulate surfactant phospholipid synthesis by approximately the 
same extent and at a similar peptide concentration (i.e. ~ 3 nM). On the basis of its size 
(16 kDa) and it having many of the same characteristics as FPF, Torday et al. [7] suggested 
that leptin may be FPF. However, as NRG1β has a molecular weight within the range given 
for FPF (5-15 kDa [20]), and is produced by lung fibroblasts [8], particularly in response to 
glucocorticoids as shown in this study, it too shares many of the attributes of FPF. Given the 
strong evidence of a role for each of these in the pulmonary surfactant system, it is possible 
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Figure legends  
Figure 1: Exposure of lung fibroblasts to dexamethasone enhances both surfactant 
phospholipid synthesis in type II cells and the concentration of NRG1β in the 
conditioned media. 
Cultured fetal rat lung fibroblasts were exposed to 100 nM dexamethasone (  ) or propylene 
glycol (control,  ) for 24 hours. The conditioned media was analysed (A) for its ability to 
stimulate phosphatidylcholine synthesis in cultured fetal type II pneumocytes, or (B) for the 
concentration of NRG1β (nM), calculated using ion trap mass spectrometry. The results are 
depicted as the mean  SEM of six separate experiments. Any result that is significantly 
different from that seen in cells exposed to FCM (without dexamethasone) are denoted with 
asterisks (* p < 0.05; ** p < 0.01).       
Figure 2: Effect of NRG1β on surfactant phospholipid synthesis. 
After three days in culture, fetal rat type II pneumocytes were exposed to (A) the indicated 
concentrations of NRG1β or vehicle and (B) 6.67 nM
 
NRG1β () or vehicle (control, ). 
After 21 h exposure to the peptide, the extent of incorporation of [
3
H-methyl]-choline chloride 
into surfactant phospholipids was determined after a further incubation of (A) 6 h or (B) 2, 4 
and 6 h. The results are depicted as the mean  SEM of four separate experiments. Any 









Figure 3: Effect of NRG1β and leptin on surfactant phospholipid synthesis.  
 Cultured fetal rat type II pneumocytes were exposed to MEM
+
 containing 1.24, 3.09 and 
6.17 nM leptin (  ) or an equivalent volume of vehicle (control,  ). After a 21-hour 
exposure, the cells were further exposed to 1.0 μCi/mL [3H-methyl]-choline chloride for 
4 hours prior to determining the amount of cellular radiolabeled surfactant phospholipids. The 
results are depicted as the mean  SEM of four separate experiments. Any significant 
differences from the control (vehicle) are denoted with asterisks (* p < 0.05; ** p < 0.01).   
 
  
Table 1: Expression of the NRG1 gene in lung fibroblasts after exposure to 
dexamethasone.  
Cultured fetal rat lung fibroblasts were exposed to MEM
+
 containing 20 or 50 nM 
dexamethasone or an equivalent volume of propylene glycol (vehicle). After the indicated 
exposure time, the cells were subjected to RNA extraction and the mRNA concentration of 
these extracts quantified. The level of NRG1 mRNA was determined using multiplex qPCR 




NRG1 gene expression in lung fibroblasts after 
exposure to dexamethasone 
(relative to a control value of 1.00) 
20 nM dexamethasone 50 nM dexamethasone 
4 hours 0.93 ± 0.33 (5) 0.95 ± 0.41 (5) 
8 hours 0.89 ± 0.15 (6) 1.01 ± 0.35 (7) 



























































































































































































Control Leptin            
20 ng/mL            
(1.24 nM) 
Leptin            
50 ng/mL            
(3.09 nM) 
Leptin            










































 Dexamethasone elevates neuregulin-1β concentration in fibroblast-conditioned media.  
 This effect is not the result of increased neuregulin-1β gene expression.  
 Surfactant phospholipid synthesis in type II cells is stimulated by neuregulin-1β.  
 It is concluded that neuregulin-1β is a likely component of fibroblast-pneumocyte 
factor.  
 
